NCT04436562View on ClinicalTrials.gov

Study of the Absorption, Metabolism, and Excretion Following a Single Dose of [14C]-Poziotinib in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 29, 2020

Primary Completion Date

July 17, 2020

Study Completion Date

July 17, 2020

Conditions

Healthy

Interventions

DRUG

[14C]-Poziotinib

Single oral administration of 8 mg (as the hydrocholoride salt) of \[14C\]-poziotinib

Trial Locations (1)

53704

Covance Clinical Research Unit, Inc., Madison

All Listed Sponsors

lead

Spectrum Pharmaceuticals, Inc

INDUSTRY

NCT04436562 - Study of the Absorption, Metabolism, and Excretion Following a Single Dose of [14C]-Poziotinib in Healthy Male Subjects | Biotech Hunter | Biotech Hunter